COLLIS STEVEN H
SEC Form 4 insider trading activity
COLLIS STEVEN H has filed 7 SEC Form 4 filings (9 transaction rows) across 2 companies, including BLCO, ELV, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 28, 2026.
On the most recent filing, COLLIS STEVEN H is listed as Director at Elevance Health, Inc. Inside the rolling window, COLLIS STEVEN H reported 2 open-market purchases totaling $1.1M in ELV and BLCO and no open-market sales. The largest disclosed transaction in the window is a purchase of 3,000 ELV shares on Mar 5, 2026, worth $870K.
Companies traded
Other insiders at BLCO
Insider Buying
$1.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 16, 2025 | COR | Sale | $9.1M |
Frequently asked questions
How many SEC Form 4 filings has COLLIS STEVEN H made?
COLLIS STEVEN H has filed 7 SEC Form 4 filings (9 transaction rows) across 2 companies, including BLCO, ELV since 2025.
Which companies does COLLIS STEVEN H trade?
COLLIS STEVEN H has filed SEC Form 4 disclosures for 2 companies, including BLCO, ELV.
When was COLLIS STEVEN H's most recent SEC Form 4 filing?
COLLIS STEVEN H's most recent SEC Form 4 filing on Tracefour is dated May 28, 2026.
What is COLLIS STEVEN H's total buy and sell value in the current window?
Inside the rolling retention window, COLLIS STEVEN H bought $1.1M and sold $0 based on SEC Form 4 filings.
What was COLLIS STEVEN H's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,000 ELV shares on 2026-03-05, worth $870K, per SEC Form 4 filings.